17 November 2010
Dignitana: Dignitana launches business operations in the UK
DigniCapTM - system launched in the UK at UKONS/ BOPA 2010
Dignitana are pleased to announce the successful launch of their unique scalp cooling system - the DigniCapTM -system in the UK and are extremely pleased to announce the first results of the DigniCap in the UK and cooperation with The BUPA Cromwell Hospital, London.After more than 3 years of developing and launching new generation of the DigniCap and success Worldwide, Dignitana officially launched their UK business operations at UKONS (United Kingdom Oncology Nurses Society) and BOPA (British Oncology Pharmacists Association) in Manchester October 14th - 15th, this year.
At UKONS, Dignitana facilitated the first Independent UK Scalp Cooling and Psycho Oncology Focus Group, Chaired by Dr. Lisa Dougherty, Nurse Consultant of The Royal Marsden Hospital, London and was attended by Senior Oncology Clinicians from the National Health Service (NHS), from the Private Healthcare sector and with several international oncologists also in attendance.
The meeting was independent of any participation from any healthcare provision companies and the transcript of the meeting will be published in the European Journal of Cancer (and/ or British Journal of Nursing) in 2011. To be confirmed.
Professor Hope Rugo UCSF , Principal Investigator of the Dignitana US trials comments "I was honored to be able to make a presentation here at UKONS of our work with the DigniCap in the US and to be able to share the experience and knowledge of the UK oncologists. We expect to present results from our study to the international oncology community in 2011 in close collaboration with Dignitana"
Dignitana have been present in the UK market since March 2010 and at this time hired UK Sales Manager, Scott McGovern, who brings with him extensive knowledge of the UK oncology and medical device market. Scott has previously worked as Strategy Manager for Hospira and Sales Manager for Unomedical.
Since March 2010, Dignitana have established 5 separate independent multi-site clinical trials of the DigniCapTM -system within the NHS and the private sector. A more detailed press release on the work with the NHS will be published before the end of the year.
Dignitana CEO Martin Waleij comments "This is a great leap forward for Dignitana and we are very content with the results so far in the trial and of course to get the first UK customer on board. We expect the UK to be one of our major markets in 2011"
UK Sales Manager Scott McGovern comments "These ground-breaking independent trials allow the opportunity to prove the enhanced benefits and features of the DigniCapTM -system in a UK setting for the first time and most importantly improve the quality of care provided to patients undergoing Chemotherapy Treatment.
The oncology department at the BUPA Cromwell is made up of a highly trained specialist team treating the cancer patient with a multidisciplinary approach to their care. Because psychological considerations are viewed as important as physical, Carole Patrick, Oncology Services Manager, and Valentina Baffour-Gyawu, Chemotherapy Day Unit Manager for chemotherapy investigated the importance of quality of life and body images in patients being treated with sometimes aggressive treatment regimes.
The BUPA Cromwell team have explored different options to support their patients and have selected the DigniCapTM -system because of the ethos of the company, the product and its comfort and effect.
Oncology Services Manager Carole Patrick comments;
" The findings of the trial to date are very encouraging and has prompted us as health care professionals to explore other ways to further advance and influence results. This approach has been agreed at the first scalp cooling group meeting held at UKONS this year driven by BUPA Cromwell and the NHS.
For further information
Martin Waleij
CEO Dignitana AB
%u10FA - 733- 93 70 76
martin.waleij@dignitana.com
Dignitana bedriver verksamhet inom området medicinteknik. Bolaget har utvecklat ett patenterat skalpkylningssystem som reducerar cytostatikarelaterat (cellgift) håravfall; DigniCap™. DigniCap™-systemet har sedan 1998 genomgått omfattande utvecklingsarbete och kliniska studier. Tusentals patienter är redan framgångsrikt behandlade med DigniCap™, som nu är redo för en internationell lansering.